Trials / Completed
CompletedNCT02241135
RNActive® Rabies Vaccine (CV7201) in Healthy Adults
Phase I Safety and Immunogenicity Trial of an Investigational RNActive® Rabies Vaccine (CV7201) in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- CureVac · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this trial is to assess the safety and immunogenicity of an investigational RNActive® rabies vaccine (CV7201) in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CV7201 mRNA | CV7201 is composed of 1 RNActive® mRNA that encodes the rabies virus glycoprotein. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2018-02-08
- Completion
- 2018-02-08
- First posted
- 2014-09-16
- Last updated
- 2018-10-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02241135. Inclusion in this directory is not an endorsement.